“…Animal models document the abilities of opiate antagonists to reduce ethanol consumption. Opiate antagonists that reduce ethanol consumption in rodents include naloxone Hubbell et al 1986Hubbell et al , 1988aHunter et al 1984;Hyytia and Sinclair 1993;Myers and Critcher 1982;Petry 1995;Reid and Hunter 1984;Reid et al 1991;Samson and Doyle 1985), naltrexone (Cowen et al 1999;Davidson and Amit 1997a, b;Franck et al 1998;June et al 1998;Le et al 1993;Myers and Lankford 1996;Nestby et al 1999;Stromberg et al 1998a, b;Volpicelli et al 1986), nalmefene (June et al 1998), LY117413 (Hubbell et al 1988b), and MR2266 (Volpicelli et al 1986). The specific µ-opiate receptor (MOR) antagonists β-funaltrexamine (Stromberg et al 1998a) and CTOP (Hyytia 1993) also reduce ethanol consumption in some but not all studies (Franck et al 1998;Le et al 1993).…”